Christine Kempton MD, MSc
Academic Appointment
- Professor of Pediatrics, Aflac Cancer Center and Blood Disorders Services, Emory University
- Professor of Hematology, Department of Hematology and Medical Oncology, Emory University School of Medicine
Education
Degrees
- MSc from Emory University
- MD from Mayo Medical School
- BA from University of California, Davis
Research
Focus
- Hemophilia is a severe chronic bleeding disorder that leads to multiple long term complications. My research focuses on investigating risk factors that influence the development of such complications as inhibitor development and low bone density. Ultimately improved understanding of risk factors for inhibitor development may lead to strategies to reduce the risk development or improve eradication once an inhibitor has developed.
Publications
-
Therapeutic plasma exchange for fibrinogen-associated hyperviscosity: results of the COVID-19 PLasma EXchange (COPLEX)randomized controlled trial.
J Thromb Haemost Volume: 23 Page(s): 1393 - 1400
04/01/2025 Authors: Maier CL; Nakahara H; Barker NA; Auld SC; Truong AD; Friend S; Caridi-Scheible M; Connor M; Gaddh M; Cobb J -
Global patterns of hemophilia drug trials, hemophilia care, and health care measures
Research and Practice in Thrombosis and Haemostasis Volume: 9
02/01/2025 Authors: Fedewa SA; Valentino LA; Koo A; Cafuir L; Gillespie TW; Buckner TW; Tran DQ; Antun A; Kempton CL -
Is a Victim Mindset Perpetuating Burnout in Healthcare?
Am J Med Volume: 138 Page(s): 3 - 4
01/01/2025 Authors: Kempton CL -
Assessment of joint health in females with haemophilia: The carriers ultrasound project (CUP) study.
Haemophilia Volume: 30 Page(s): 1422 - 1428
11/01/2024 Authors: Corrales-Medina FF; Fraga K; D'Almeida Bastos M; Rafique A; Kempton CL; Vijayvargia P; Davis JA; Kronenfeld RS -
Women and girls' participation in haemophilia clinical trials.
Haemophilia Volume: 30 Page(s): 1440 - 1443
11/01/2024 Authors: Fedewa SA; Cafuir L; Valentino LA; Koo A; Antun A; Kempton CL -
Differences and similarities in patient-reported outcomes among men and women with haemophilia.
Haemophilia Volume: 30 Page(s): 1383 - 1392
11/01/2024 Authors: Kempton CL; Guasch SA; Buckner TW; Mattis S; Fedewa SA -
Racial and Ethnic Differences in Distress, Depression, and Quality of Life in people with hemophilia.
J Racial Ethn Health Disparities Volume: 11 Page(s): 1394 - 1404
06/01/2024 Authors: Fedewa SA; Buckner TW; Parks SG; Tran DQ; Cafuir L; Antun AG; Mattis S; Kempton CL -
Race and ethnicity reporting and representation in hemophilia clinical trials.
Blood Adv Volume: 8 Page(s): 2351 - 2360
05/28/2024 Authors: Fedewa SA; Valentino LA; Koo A; Cafuir L; Tran DQ; Antun A; Kempton CL -
Race and ethnicity and the success of immune tolerance induction among people with severe haemophilia A in the United States.
Haemophilia Volume: 30 Page(s): 628 - 637
05/01/2024 Authors: Fedewa SA; Kempton CL -
Defining the impact of immune tolerance induction on clinically relevant outcomes in a US cohort of severe hemophilia A.
Blood Adv Volume: 8 Page(s): 1190 - 1199
03/12/2024 Authors: Kempton CL; Fedewa SA -
Laboratory Evaluation of Thrombotic Thrombocytopenic Purpura
Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects Page(s): 779 - 781
01/01/2024 Authors: Kempton CL; Antun AG -
Thrombotic Thrombocytopenic Purpura
Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects Page(s): 547 - 551
01/01/2024 Authors: Kempton CL; Antun AG -
Acquired Coagulation Factor Inhibitors
Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects Page(s): 641 - 645
01/01/2024 Authors: Kempton CL; Tran DQ -
Bleeding Disorders in Pregnancy
Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects Page(s): 595 - 599
01/01/2024 Authors: Kempton CL; Woods K -
Characterization of Joint Disease in Women with Hemophilia: The Carriers Ultrasound Project (CUP) Study
Volume: 142
11/02/2023 Authors: Kronenfeld RS; Fraga K; Bastos MD; Rafique A; Kempton C; Davis J; Corrales-Medina FF -
Characteristics Associated with the Success of Immune Tolerance Induction Among People with Severe Hemophilia a in the United States
Volume: 142
11/02/2023 Authors: Fedewa S; Payne AB; Cafuir L; Tran DQ; Antun AG; Kempton C -
Reporting of Race and Ethnicity and Representation in Hemophilia Clinical Trials
Volume: 142
11/02/2023 Authors: Fedewa S; Valentino L; Abouyabis AN; Cafuir L; Tran DQ; Antun AG; Kempton C -
Race, ethnicity, and immune tolerance induction in hemophilia A in the United States.
Res Pract Thromb Haemost Volume: 7 Page(s): 102251
11/01/2023 Authors: Kempton CL; Payne AB; Fedewa SA -
Racial and ethnic differences in reported haemophilia death rates in the United States.
Haemophilia Volume: 29 Page(s): 1410 - 1418
11/01/2023 Authors: Fedewa SA; Payne AB; Tran D; Cafuir L; Antun A; Kempton CL -
Cost-effectiveness of prophylactic emicizumab versus prophylactic recombinant factor VIII in patients with moderate or mild hemophilia A without inhibitors in the United States.
Am J Hematol Volume: 98 Page(s): E247 - E250
09/01/2023 Authors: Potnis KC; Viswanathan G; Bona RD; Ito S; Kempton CL; Pandya A; Krumholz HM; Goshua G -
Corrigendum to 'Efficacy of emicizumab is maintained throughout dosing intervals for bleed prophylaxis' [Research and Practice in Thrombosis and Haemostasis, Volume 7, Issue 2, February 2023, 100077].
Res Pract Thromb Haemost Volume: 7 Page(s): 100191
05/01/2023 Authors: Pipe SW; Trzaskoma B; Minhas M; Lehle M; Ko RH; Gao L; Mahlangu J; Kempton CL; Kessler CM; Kruse-Jarres R -
Cross-sectional study evaluating the association of haemophilia-related distress and clinically relevant outcomes.
Haemophilia Volume: 29 Page(s): 505 - 512
03/01/2023 Authors: Guasch S; Scott LC; Figueroa J; Buckner TW; Mattis S; Tran DQ; Kempton CL -
Efficacy of emicizumab is maintained throughout dosing intervals for bleed prophylaxis.
Res Pract Thromb Haemost Volume: 7 Page(s): 100077
02/01/2023 Authors: Pipe SW; Trzaskoma B; Minhas M; Lehle M; Ko RH; Gao L; Mahlangu J; Kempton CL; Kessler CM; Kruse-Jarres R -
Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studies.
Blood Adv Volume: 6 Page(s): 6140 - 6150
12/27/2022 Authors: Kruse-Jarres R; Peyvandi F; Oldenburg J; Chang T; Chebon S; Doral MY; Croteau SE; Lambert T; Kempton CL; Pipe SW -
Characteristics Associated with Receipt of Immune Tolerance Induction Among Patients with Severe Hemophilia a in the United States in the Pre-Emicizumab Era
Volume: 140 Page(s): 10752 - 10754
11/15/2022 Authors: Kempton CL; Fedewa S; Payne AB -
Sex-Differences in Distress, Quality of Life, and Depression Among People with Hemophilia
Volume: 140 Page(s): 8005 - 8007
11/15/2022 Authors: Parks SG; Fedewa S; Buckner T; Antun AG; Cafuir L; Tran DQ; Mattis S; Kempton CL -
Racial/Ethnic Disparities in Hemophilia-Related Distress
Volume: 140 Page(s): 1232 - 1233
11/15/2022 Authors: Fedewa S; Buckner T; Tran DQ; Cafuir L; Antun AG; Mattis S; Kempton CL -
Effect of emicizumab prophylaxis on bone and joint health markers in people with haemophilia A without factor VIII inhibitors in the HAVEN 3 study.
Haemophilia Volume: 28 Page(s): 1033 - 1043
11/01/2022 Authors: Kiialainen A; Niggli M; Kempton CL; Castaman G; Chang T; Paz-Priel I; Adamkewicz JI; Levy GG -
Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1-3.
Res Pract Thromb Haemost Volume: 6 Page(s): e12782
08/01/2022 Authors: Callaghan MU; Asikanius E; Lehle M; Oldenburg J; Mahlangu J; Uguen M; Chebon S; Kruse-Jarres R; Jimnez-Yuste V; Shima M -
EARLY REAL-WORLD EXPERIENCE WITH EMICIZUMAB AND CONCOMITANT FACTOR VIII REPLACEMENT PRODUCTS IN ADULT, MALE PEOPLE WITH HEMOPHILIA A WITHOUT INHIBITORS
Volume: 25 Page(s): S359 - S359
07/01/2022 Authors: Cafuir L; Estrin A; Chen E; Hinds D; Prince P; Thorburn J; Mead H; Kempton C -
Comparing direct oral anticoagulants and vitamin K antagonist use in morbidly obese patients with venous thromboembolism: A single center retrospective cohort study.
EJHaem Volume: 3 Page(s): 457 - 462
05/01/2022 Authors: Scott LC; Li J; Cafuir LA; Gaddh M; Kempton CL -
Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remain.
Haemophilia Volume: 28 Page(s): 453 - 461
05/01/2022 Authors: Berntorp E; LeBeau P; Ragni MV; Borhany M; Abajas YL; Tarantino MD; Holstein K; Croteau SE; Liesner R; Tarango C -
Clinical Outcomes of Critically III Patients with COVID-19 by Race.
J Racial Ethn Health Disparities Volume: 9 Page(s): 385 - 389
04/01/2022 Authors: Marmarchi F; Liu M; Rangaraju S; Auld SC; Creel-Bulos MC; Kempton CL; Sharifpour M; Gaddh M; Sniecinski R; Maier CL -
Pulmonary Embolism and DVT
Handbook of Outpatient Cardiology Page(s): 371 - 384
01/01/2022 Authors: Wang S; Kempton C -
Early real-world experience with emicizumab and concomitant factor VIII replacement products in adult males with Hemophilia A without inhibitors.
J Med Econ Volume: 25 Page(s): 984 - 992
01/01/2022 Authors: Cafuir L; Estrin A; Chen E; Hinds D; Prince P; Thorburn J; Mead H; Kempton CL -
Shortening the Haemophilia Activities List (HAL) from 42 items to 18 items.
Haemophilia Volume: 27 Page(s): 1062 - 1070
11/01/2021 Authors: Kuijlaars IAR; van der Net J; Buckner TW; Kempton CL; Schutgens REG; Fischer K -
The B-Natural study-The outcome of immune tolerance induction therapy in patients with severe haemophilia B.
Haemophilia Volume: 27 Page(s): 802 - 813
09/01/2021 Authors: Astermark J; Holstein K; Abajas YL; Kearney S; Croteau SE; Liesner R; Funding E; Kempton CL; Acharya S; Lethagen S -
Thrombocytopenia Induced by Polysulfone Dialysis Membranes.
Am J Case Rep Volume: 22 Page(s): e932045
07/03/2021 Authors: Claudio-Gonzalez I; Ravindranathan D; Kempton CL; Bailey JL; Wall SM -
F5-Atlanta: A novel mutation in F5 associated with enhanced East Texas splicing and FV-short production.
J Thromb Haemost Volume: 19 Page(s): 1653 - 1665
07/01/2021 Authors: Zimowski KL; Petrillo T; Ho MD; Wechsler J; Shields JE; Denning G; Jhita N; Rivera AA; Escobar MA; Kempton CL -
An evaluation of PROMIS health domains in adults with haemophilia: A cross-sectional study.
Haemophilia Volume: 27 Page(s): 375 - 382
05/01/2021 Authors: Barry V; Buckner TW; Lynch ME; Figueroa J; Mattis S; Stout ME; Kempton CL -
Therapeutic plasma exchange for COVID-19-associated hyperviscosity.
Transfusion Volume: 61 Page(s): 1029 - 1034
04/01/2021 Authors: Truong AD; Auld SC; Barker NA; Friend S; Wynn AT; Cobb J; Sniecinski RM; Tanksley C-L; Polly DM; Gaddh M -
Prophylaxis in hemophilia: how much is enough?
Blood Volume: 137 Page(s): 1709 - 1711
04/01/2021 Authors: Kempton CL -
Markers of Coagulation and Hemostatic Activation Identify Covid-19 Patients at High Risk for Thrombotic Events
Volume: 52
03/01/2021 Authors: Alabyad D; Rangaraju S; Liu M; Imran R; Kempton CL; Sharifpour M; Auld SC; Gaddh M; Sniecinski R; Maier CL -
Outcomes for studies assessing the efficacy of hemostatic therapies in persons with congenital bleeding disorders.
Haemophilia Volume: 27 Page(s): 211 - 220
03/01/2021 Authors: Aquino CC; Borg Debono V; Germini F; Pete D; Kempton CL; Young G; Sidonio R; Croteau SE; Dunn AL; Key NS -
Development and testing of the Satisfaction Questionnaire with Intravenous or Subcutaneous Hemophilia Injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis in persons with haemophilia A without FVIII inhibitors.
Haemophilia Volume: 27 Page(s): 221 - 228
03/01/2021 Authors: Kempton C; Trask P; Parnes A; Niggli M; Campinha-Bacote A; U Callaghan M; O'Connell N; Paz-Priel I; Mahlangu JN -
Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU.
Shock Volume: 55 Page(s): 316 - 320
03/01/2021 Authors: Creel-Bulos C; Auld SC; Caridi-Scheible M; Barker NA; Friend S; Gaddh M; Kempton CL; Maier CL; Nahab F; Sniecinski R -
Management of comorbidities in haemophilia.
Haemophilia Volume: 27 Suppl 3 Page(s): 37 - 45
02/01/2021 Authors: Kempton CL; Makris M; Holme PA -
Validation of an admission coagulation panel for risk stratification of COVID-19 patients.
PLoS One Volume: 16 Page(s): e0248230
01/01/2021 Authors: Alabyad D; Rangaraju S; Liu M; Imran R; Kempton CL; Sharifpour M; Auld SC; Gaddh M; Sniecinski R; Maier CL -
Management of inhibitors in persons with non-severe hemophilia A in the United States.
Am J Hematol Volume: 96 Page(s): E9 - E11
01/01/2021 Authors: Lim MY; Cheng D; Recht M; Kempton CL; Key NS -
Validation of a new instrument to measure disease-related distress among patients with haemophilia.
Haemophilia Volume: 27 Page(s): 60 - 68
01/01/2021 Authors: Kempton CL; Michaels Stout M; Barry V; Figueroa J; Buckner TW; Gillespie S; Ellen Lynch M; Mattis S; Whitten S; McCracken C -
Natural history study of factor IX deficiency with focus on treatment and complications (B-Natural).
Haemophilia Volume: 27 Page(s): 49 - 59
01/01/2021 Authors: Shapiro AD; Ragni MV; Borhany M; Abajas YL; Tarantino MD; Holstein K; Croteau SE; Liesner R; Tarango C; Carvalho M -
Trends and diagnostic value of D-dimer levels in patients hospitalized with coronavirus disease 2019.
Medicine (Baltimore) Volume: 99 Page(s): e23186
11/13/2020 Authors: Creel-Bulos C; Liu M; Auld SC; Gaddh M; Kempton CL; Sharifpour M; Sniecinski RM; Maier CL; Nahab FB; Rangaraju S -
Evaluating international Haemophilia Joint Health Score (HJHS) results combined with expert opinion: Options for a shorter HJHS.
Haemophilia Volume: 26 Page(s): 1072 - 1080
11/01/2020 Authors: Kuijlaars IAR; van der Net J; Feldman BM; Aspdahl M; Bladen M; de Boer W; Cuesta-Barriuso R; Matlary RED; Funk SM; Hilliard P -
Inhibitors and mortality in persons with nonsevere hemophilia A in the United States.
Blood Adv Volume: 4 Page(s): 4739 - 4747
10/13/2020 Authors: Lim MY; Cheng D; Recht M; Kempton CL; Key NS -
High hemophilia-related distress is associated with target joint bleeds
Volume: 26 Page(s): 129 - 129
06/01/2020 Authors: Kempton C; Barry V; Buckner T; Lynch ME; Mattis S; Stout MM; Whitten S; McCracken C -
Management of inhibitors in non-severe Hemophilia A Patients in the United States: A multicenter, registry-based, observational study
Volume: 26 Page(s): 32 - 32
06/01/2020 Authors: Lim M; Cheng D; Kempton C; Key N -
Outcomes of direct oral anticoagulant- and warfarin-associated hemorrhage: A single center retrospective cohort study.
Thromb Res Volume: 189 Page(s): 128 - 131
05/01/2020 Authors: Cafuir L; Cheng E; Kempton C -
Bone and joint health markers in persons with haemophilia A (PwHA) treated with emicizumab in HAVEN 3
Volume: 189 Page(s): 151 - 152
04/01/2020 Authors: Kiialainen A; Niggli M; Kempton C; Castaman G; Chang T; Paz-Priel I; Adamkewicz J; Levy G -
The effect of psychological distress on health outcomes: A systematic review and meta-analysis of prospective studies.
J Health Psychol Volume: 25 Page(s): 227 - 239
02/01/2020 Authors: Barry V; Stout ME; Lynch ME; Mattis S; Tran DQ; Antun A; Ribeiro MJ; Stein SF; Kempton CL -
Bone and Joint Health Markers in Persons with Hemophilia A (PwHA) Treated with Emicizumab in HAVEN 3
Volume: 134
11/13/2019 Authors: Kiialainen A; Niggli M; Kempton CL; Castaman G; Chang TY; Paz-Priel I; Adamkewicz JI; Levy GG -
All-Cause and Inhibitor-Related Mortality in Non-Severe Hemophilia. Patients in the United States
Volume: 134
11/13/2019 Authors: Lim MY; Cheng D; Kempton CL; Key NS -
Validation of Instrument to Assess Hemophilia-Related Distress
Volume: 134
11/13/2019 Authors: Kempton CL; Barry V; Buckner TW; Figueroa J; Mattis S; Lynch ME; Stout ME; Whitten S; Gillespie S; McCracken C -
Disease-related distress among adults with haemophilia: A qualitative study.
Haemophilia Volume: 25 Page(s): 988 - 995
11/01/2019 Authors: Mattis S; Barry V; Taylor N; Lynch ME; Tatum K; Whitten S; Kempton CL -
Exploring changes in distress among individuals with bleeding disorders: What is linked to improvements in distress?
J Health Psychol Volume: 24 Page(s): 1724 - 1733
10/01/2019 Authors: Barry V; Lynch ME; Tran DQ; Antun A; DeBalsi A; Hicks D; Lasseter F; Mattis S; Ribeiro MJ; Stein SF -
Factor VIII prophylaxis effects outweigh other hemostasis contributors in predicting severe haemophilia A joint outcomes.
Haemophilia Volume: 25 Page(s): 867 - 875
09/01/2019 Authors: Warren BB; Jacobson L; Kempton C; Buchanan GR; Recht M; Brown D; Leissinger C; Shapiro AD; Abshire TC; Manco-Johnson MJ -
Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review
Research and Practice in Thrombosis and Haemostasis Volume: 3 Page(s): 528 - 541
07/01/2019 Authors: Yu JK; Iorio A; Edginton AN; Ahuja S; lvarez Romn MT; Arrieta ME; Arola M; Barillari G; Balasa V; Belletrutti M -
Emicizumab for hemophilia A without inhibitors.
Expert Rev Hematol Volume: 12 Page(s): 515 - 524
07/01/2019 Authors: Cafuir L; Kruse-Jarres R; Mancuso ME; Kempton CL -
Evaluation of Treatment-Dose Enoxaparin in Acutely Ill Morbidly Obese Patients at an Academic Medical Center: A Randomized Clinical Trial.
Ann Pharmacother Volume: 53 Page(s): 567 - 573
06/01/2019 Authors: Curry MA; LaFollette JA; Alexander BR; Evans KS; Tran RH; Kempton CL -
Bleeding and safety outcomes in persons with haemophilia A without inhibitors: Results from a prospective non-interventional study in a real-world setting.
Haemophilia Volume: 25 Page(s): 213 - 220
03/01/2019 Authors: Kruse-Jarres R; Oldenburg J; Santagostino E; Shima M; Kempton CL; Kessler CM; Lehle M; Chebon S; Selak Bienz N; Asikanius E -
Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice.
Blood Adv Volume: 3 Page(s): 288 - 300
02/12/2019 Authors: Weitzmann MN; Roser-Page S; Vikulina T; Weiss D; Hao L; Baldwin WH; Yu K; Del Mazo Arbona N; McGee-Lawrence ME; Meeks SL -
Surgical procedures in persons with haemophilia A (PWHA) without inhibitors receiving emicizumab - Experience from the HAVEN 3 study
Volume: 25 Page(s): 33 - 33
02/01/2019 Authors: Santagostino E; Parnes A; Dhalluin C; Oldenburg J; Niggli M; Lambert T; Kempton C; Ko RH; Han JW; Wozny T -
Laboratory Evaluation of Thrombotic Thrombocytopenic Purpura
Page(s): 919 - 923
01/01/2019 Authors: Kempton CL; Antun AG -
Thrombotic Thrombocytopenic Purpura
Page(s): 649 - 654
01/01/2019 Authors: Kempton CL; Antun AG -
Bleeding Disorders in Pregnancy
Page(s): 711 - 718
01/01/2019 Authors: Kempton CL; Woods K -
Acquired Coagulation Factor Inhibitors
Page(s): 761 - 766
01/01/2019 Authors: Kempton CL; Tran DQ -
Epidemiology of Inhibitors in Persons with Severe Hemophilia a in the United States: Analyses of a National Database
Volume: 132
11/29/2018 Authors: Sande CM; Payne AB; Kempton CL; Manco-Johnson MJ; Sharathkumar A -
Outcomes of Direct Oral Anticoagulant- and Warfarin-Associated Hemorrhage: A Single Center Retrospective Cohort Study
Volume: 132
11/29/2018 Authors: Cafuir L; Cheng E; Kempton CL -
Chronic Kidney Disease (CKD) in the US Hemophilia Population: A Cohort Study
Volume: 132
11/29/2018 Authors: Sood SL; Cheng D; Shapiro A; Kessler CM; Key NS; Quon D; Eyster ME; Manco-Johnson MJ; Kempton CL; Cuker A -
Untreated Bleeds May Be Historically Under-Reported and More Prevalent in People with Hemophilia A with Inhibitors: An Examination of Bleed Data from a Prospective, Non-Interventional Study
Volume: 132
11/29/2018 Authors: Callaghan MU; Asikanius E; Lehle M; Oldenburg J; Mahlangu J; Uguen M; Chebon S; Kruse-Jarres R; Jimenez-Yuste V; Shima M -
An Evaluation of Promis Health Domains in Adults with Hemophilia: A Cross-Sectional Study
Volume: 132
11/29/2018 Authors: Barry V; Buckner TW; Mattis S; Stout ME; Kempton CL -
A cross-sectional study of non-attendance among patients at a US hemophilia treatment center 2010-2014.
Haemophilia Volume: 24 Page(s): 902 - 910
11/01/2018 Authors: Barry V; Steffens C; Mattis S; Sidonio RF; Tran DQ; Kempton CL -
DEVELOPMENT OF A HEMOPHILIA DISTRESS TOOL
Volume: 93 Page(s): E46 - E47
09/01/2018 Authors: Michaels ME; Barry V; Mattis S; Lynch ME; Kempton CL -
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors.
N Engl J Med Volume: 379 Page(s): 811 - 822
08/30/2018 Authors: Mahlangu J; Oldenburg J; Paz-Priel I; Negrier C; Niggli M; Mancuso ME; Schmitt C; Jimnez-Yuste V; Kempton C; Dhalluin C -
HLA-DRB1-factor VIII binding is a risk factor for inhibitor development in nonsevere hemophilia: a case-control study.
Blood Adv Volume: 2 Page(s): 1750 - 1755
07/24/2018 Authors: Kempton CL; Payne AB -
A cross-sectional analysis of cardiovascular disease in the hemophilia population.
Blood Adv Volume: 2 Page(s): 1325 - 1333
06/12/2018 Authors: Sood SL; Cheng D; Ragni M; Kessler CM; Quon D; Shapiro AD; Key NS; Manco-Johnson MJ; Cuker A; Kempton C -
Functional impairment in adults with mild-to-severe hemophilia: insights from the Hemophilia Experiences, Results and Opportunities (HERO), Pain, Functional Impairment, and Quality of Life (P-FiQ), and Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S) studies
Volume: 24 Page(s): 83 - 84
05/01/2018 Authors: Cooper D; Hernandez G; Baumann K; Wang M; Recht M; Owens W; Kempton C -
| Pain in adults with mild-to-severe hemophilia: Insights from the Hemophilia Experiences, Results and Opportunities (HERO), Pain, Functional Impairment, and Quality of Life (P-FiQ), and Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S) studies
Volume: 24 Page(s): 82 - 82
05/01/2018 Authors: Cooper D; Quon D; Witkop M; Recht M; Kessler C; Batt K; Baumann K; Kempton C; Buckner T -
Emicizumab Prophylaxis in Adolescent/Adult Patients with Haemophilia A Previously Receiving Episodic or Prophylactic Bypassing Agent Treatment: Updated Analyses from the HAVEN 1 Study
Volume: 181 Page(s): 127 - 127
04/01/2018 Authors: Mancuso ME; Oldenburg J; Callaghan M; Kruse-Jarres R; Kempton C; Xu J; Catalani O; Asikanius E; Levy GG; Shima M -
Assessments of pain, functional impairment, anxiety, and depression in US adults with hemophilia across patient-reported outcome instruments in the Pain, Functional Impairment, and Quality of Life (P-FiQ) study.
Eur J Haematol Volume: 100 Suppl 1 Page(s): 5 - 13
04/01/2018 Authors: Buckner TW; Batt K; Quon D; Witkop M; Recht M; Kessler C; Baumann K; Hernandez G; Wang M; Cooper DL -
What can we learn from using formal patient-reported outcome instruments to assess pain, functional impairment, anxiety, and depression in US adults with hemophilia?
Eur J Haematol Volume: 100 Suppl 1 Page(s): 3 - 4
04/01/2018 Authors: Buckner TW; Batt K; Cooper DL; Kempton CL -
Factors associated with pain severity, pain interference, and perception of functional abilities independent of joint status in US adults with hemophilia: Multivariable analysis of the Pain, Functional Impairment, and Quality of Life (P-FiQ) study.
Eur J Haematol Volume: 100 Suppl 1 Page(s): 25 - 33
04/01/2018 Authors: Kempton CL; Buckner TW; Fridman M; Iyer NN; Cooper DL -
Impact of pain and functional impairment in US adults with haemophilia: Patient-reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P-FiQ) study.
Volume: 24 Page(s): 261 - 270
03/01/2018 Authors: Kempton CL; Recht M; Neff A; Wang M; Buckner TW; Soni A; Quon D; Witkop M; Boggio L; Gut RZ -
Bleeding events and safety outcomes in persons with hemophilia A (PWHA) without inhibitors: non-interventional study (NIS) from a real-world setting
Volume: 24 Page(s): 116 - 117
02/01/2018 Authors: Kruse-Jarres R; Oldenburg J; Santagostino E; Shima M; Kempton C; Kessler CM; Lehle M; Chebon S; Bienz NS; Asikanius E -
Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients.
Haemophilia Volume: 24 Page(s): 104 - 112
01/01/2018 Authors: Collins PW; Quon DVK; Makris M; Chowdary P; Kempton CL; Apte SJ; Ramanan MV; Hay CRM; Drobic B; Hua Y -
HLA-DRB1-Peptide Binding Prediction and Risk of Inhibitor Development in Non-Severe Hemophilia a
Volume: 130
12/07/2017 Authors: Kempton CL; Payne AB -
Emicizumab Prophylaxis in Adolescent/Adult Patients with Hemophilia A Previously Receiving Episodic or Prophylactic Bypassing Agent Treatment: Updated Analyses from the HAVEN 1 Study
Volume: 130
12/07/2017 Authors: Mancuso ME; Callaghan MU; Kruse-Jarres R; Kempton CL; Xu J; Catalani O; Asikanius E; Levy GG; Shima M; Young G -
Characteristics of Males with Hemophilia in the United States Hemophilia Treatment Center Network (USHTCN) with New-Onset Elevated Inhibitor Titers, December 15, 2013-December 31, 2016
Volume: 130
12/07/2017 Authors: Manco-Johnson MJ; Soucie JM; Sharathkumar A; Bethea F; Kempton CL; Payne AB; Wang M; Miller CH -
Factor V Atlanta: A Novel Mutation in the F5 Gene Reveals Potential New Cis-Acting Elements Involved in Regulating FV-Short and TFPI Levels
Volume: 130
12/07/2017 Authors: Zimowski KL; Ho MD; Shields JE; Denning G; Petrillo T; Jhita N; Rivera AA; Escobar MA; Kempton CL; Doering CB -
Mortality Trends and Causes of Death in Persons with Hemophilia in the United States, 1999-2014
Volume: 130
12/07/2017 Authors: Payne AB; Ghaji N; Mehal JM; Chapman C; Haberling DL; Kempton CL; Bean CJ; Soucie JM; Hooper WC -
Chronic Kidney Disease in the US Hemophilia Population: A Cohort Study
Volume: 130
12/07/2017 Authors: Sood SL; Cheng D; Shapiro AD; Kessler CM; Key NS; Quon DV; Eyster ME; Manco-Johnson MJ; Kempton CL; Cuker A -
Effect of late prophylaxis in hemophilia on joint status: a randomized trial.
J Thromb Haemost Volume: 15 Page(s): 2115 - 2124
11/01/2017 Authors: Manco-Johnson MJ; Lundin B; Funk S; Peterfy C; Raunig D; Werk M; Kempton CL; Reding MT; Goranov S; Gercheva L -
Limit of detection and threshold for positivity of the Centers for Disease Control and Prevention assay for factor VIII inhibitors.
J Thromb Haemost Volume: 15 Page(s): 1971 - 1976
10/01/2017 Authors: Miller CH; Boylan B; Shapiro AD; Lentz SR; Wicklund BM; Hemophilia Inhibitor Research Study Investigators -
Current and emerging factor VIII replacement products for hemophilia A.
Ther Adv Hematol Volume: 8 Page(s): 303 - 313
10/01/2017 Authors: Cafuir LA; Kempton CL -
Self-reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study
HAEMOPHILIA Volume: 23 Page(s): 556 - 565
07/01/2017 Authors: Witkop M; Neff A; Buckner TW; Wang M; Batt K; Kessler CM; Quon D; Boggio L; Recht M; Baumann K -
Acquired hemophilia A: Updated review of evidence and treatment guidance.
Am J Hematol Volume: 92 Page(s): 695 - 705
07/01/2017 Authors: Kruse-Jarres R; Kempton CL; Baudo F; Collins PW; Knoebl P; Leissinger CA; Tiede A; Kessler CM -
Self-reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study.
Haemophilia Volume: 23 Page(s): 556 - 565
07/01/2017 Authors: Witkop M; Neff A; Buckner TW; Wang M; Batt K; Kessler CM; Quon D; Boggio L; Recht M; Baumann K -
MODELING JOINT STATUS AND OTHER FACTORS ASSOCIATED WITH PERCEPTION OF PAIN SEVERITY/INTERFERENCE AND FUNCTIONAL IMPAIRMENT IN US ADULTS WITH HEMOPHILIA: ANALYSIS OF THE PAIN, FUNCTIONAL IMPAIRMENT, AND QUALITY OF LIFE (P-FIQ) STUDY
Volume: 20 Page(s): A227 - A227
05/01/2017 Authors: Kempton C; Buckner T; Fridman M; Iyer NN; Cooper DL -
Moving from parked to neutral(izing).
Blood Volume: 129 Page(s): 1233 - 1234
03/09/2017 Authors: Kempton CL -
Internal consistency and item-total correlation of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adult people with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study.
Patient Prefer Adherence Volume: 11 Page(s): 1831 - 1839
01/01/2017 Authors: Wang M; Batt K; Kessler C; Neff A; Iyer NN; Cooper DL; Kempton CL -
Known-group validity of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study.
Patient Prefer Adherence Volume: 11 Page(s): 1745 - 1753
01/01/2017 Authors: Buckner TW; Wang M; Cooper DL; Iyer NN; Kempton CL -
Reliability of patient-reported outcome instruments in US adults with hemophilia: the Pain, Functional Impairment and Quality of life (P-FiQ) study.
Patient Prefer Adherence Volume: 11 Page(s): 1603 - 1612
01/01/2017 Authors: Kempton CL; Wang M; Recht M; Neff A; Shapiro AD; Soni A; Kulkarni R; Buckner TW; Batt K; Iyer NN -
Construct validity of patient-reported outcome instruments in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study.
Patient Prefer Adherence Volume: 11 Page(s): 1369 - 1380
01/01/2017 Authors: Batt K; Recht M; Cooper DL; Iyer NN; Kempton CL -
Physician trust and depression influence adherence to factor replacement: a single-centre cross-sectional study.
Haemophilia Volume: 23 Page(s): 98 - 104
01/01/2017 Authors: Tran DQ; Barry V; Antun A; Ribeiro M; Stein S; Kempton CL -
Linear and Logistic Regression Models of Patient-Reported Outcomes and Patient Characteristics in US Adults with Hemophilia from the Pain, Functional Impairment, and Quality of Life (P-FiQ) Study
Volume: 128
12/02/2016 Authors: Batt K; Recht M; Wang M; Quon DV; Boggio LN; Kessler CM; Buckner TW; Neff AT; Iyer NN; Cooper DL -
Survey of the anti-factor IX immunoglobulin profiles in patients with hemophilia B using a fluorescence-based immunoassay.
J Thromb Haemost Volume: 14 Page(s): 1931 - 1940
10/01/2016 Authors: Boylan B; Rice AS; Neff AT; Manco-Johnson MJ; Kempton CL; Miller CH; Hemophilia Inhibitor Research Study Investigators -
Interim results from a large multinational extension trial (guardian() 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A.
Haemophilia Volume: 22 Page(s): e445 - e449
09/01/2016 Authors: Lentz SR; Cerqueira M; Janic D; Kempton C; Matytsina I; Misgav M; Oldenburg J; Ozelo M; Recht M; Rosholm A -
Interim results from a large multinational extension trial (guardian (TM) 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A
HAEMOPHILIA Volume: 22 Page(s): E445 - E449
09/01/2016 Authors: Lentz SR; Cerqueira M; Janic D; Kempton C; Matytsina I; Misgav M; Oldenburg J; Ozelo M; Recht M; Rosholm A -
SAFETY OF TUROCTOCOG ALFA FOR PROPHYLAXIS AND TREATMENT OF BLEEDING EPISODES IN PATIENTS WITH SEVERE HEMOPHILIA A: RESULTS FROM THE GUARDIAN (TM) 2 TRIAL
AMERICAN JOURNAL OF HEMATOLOGY Volume: 91 Page(s): E421 - E421
09/01/2016 Authors: Recht M; Lentz SR; Kempton CL; Matytsina I; Rosholm A -
Coagulation factor inhibitors: Diagnosis and management
Nonmalignant Hematology: Expert Clinical Review: Questions and Answers Page(s): 263 - 272
08/24/2016 Authors: Reipert BM; Kempton CL -
Prospective, multicenter study of postoperative deep-vein thrombosis in patients with haemophilia undergoing major orthopaedic surgery.
Thromb Haemost Volume: 116 Page(s): 42 - 49
07/04/2016 Authors: Buckner TW; Leavitt AD; Ragni M; Kempton CL; Eyster ME; Cuker A; Lentz SR; Ducore J; Leissinger C; Wang M -
Assessments of functional impairment in US adults with hemophilia across patient-reported outcomes in the pain, functional impairment, and quality of life (P-FiQ) study
HAEMOPHILIA Volume: 22 Page(s): 89 - 89
07/01/2016 Authors: Hernandez G; Recht M; Wang M; Baumann K; Cooper DL; Kempton CL -
Hemophilia joint health score v2.1 in US adults with hemophilia in the pain, functional impairment, and quality of life (P-FiQ) study
HAEMOPHILIA Volume: 22 Page(s): 92 - 93
07/01/2016 Authors: Hernandez G; Baumann K; Recht M; Neff A; Quon D; Kessler C; Wang M; Buckner TW; Boggio L; Gut RZ -
Assessments of anxiety and depression in US adult people with hemophilia across patient-reported outcomes in the pain, functional impairment, and quality of life (P-FiQ) study
HAEMOPHILIA Volume: 22 Page(s): 112 - 112
07/01/2016 Authors: Batt K; Witkop M; Gut RZ; Cooper DL; Kempton CL -
Assessments of pain in US adults with hemophilia across patient-reported outcomes in the pain, functional impairment, and quality of life (P-FiQ) study
HAEMOPHILIA Volume: 22 Page(s): 94 - 94
07/01/2016 Authors: Witkop M; Buckner TW; Recht M; Kessler C; Batt K; Baumann K; Gut RZ; Cooper DL; Kempton CL -
Expecting the Unexpected.
J Oncol Pract Volume: 12 Page(s): 533 - 534
06/01/2016 Authors: Antun A; Kempton CL -
Internal consistency and item-total correlation of patient-reported outcome (PRO) instruments and hemophilia joint health score v2.1 (HJHS) in US adult people with hemophilia (PWH): results from the pain, functional impairment, and quality of life (P-FiQ) study
JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 14 Page(s): 48 - 48
05/01/2016 Authors: Wang M; Batt K; Kessler C; Neff A; Iyer N; Cooper DL; Kempton C -
Known-group validity of patient-reported outcome (PRO) instruments and hemophilia joint health score v2.1 (HJHS) in US adult people with hemophilia (PWH): results from the pain, functional impairment, and quality of life (P-FiQ) study
JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 14 Page(s): 48 - 49
05/01/2016 Authors: Buckner TW; Wang M; Cooper DL; Kempton C -
CONSTRUCT VALIDITY OF PATIENT-REPORTED OUTCOME INSTRUMENTS IN US ADULT PEOPLE WITH HEMOPHILIA (PWH): RESULTS FROM THE PAIN, FUNCTIONAL IMPAIRMENT, AND QUALITY OF LIFE (P-FIQ) STUDY
Volume: 19 Page(s): A93 - A93
05/01/2016 Authors: Batt K; Recht M; Cooper DL; Iyer NN; Kempton CL -
A subset of high-titer anti-factor VIII A2 domain antibodies is responsive to treatment with factor VIII.
Blood Volume: 127 Page(s): 2028 - 2034
04/21/2016 Authors: Eubanks J; Baldwin WH; Markovitz R; Parker ET; Cox C; Kempton CL; Meeks SL -
A Cross-Sectional Analysis of Cardiovascular Disease in the Hemophilia Population
Volume: 126
12/03/2015 Authors: Sood SL; Cheng D; Ragni MV; Kessler CM; Quon D; Shapiro AD; Key NS; Manco-Johnson MJ; Cuker A; Kempton C -
Numeracy in Patients with Hemophilia
Volume: 126
12/03/2015 Authors: Tran DQ; Barry V; Antun AG; Ribeiro M; Stein SF; Kempton CL -
Non-Factor VIII Coagulation Proteins Fail to Predict Joint Outcome in Severe Hemophilia a
Volume: 126
12/03/2015 Authors: Warren BB; Jacobsen L; Villalobos-Menuey E; Abshire TC; Shapiro AD; Recht M; Brown D; Leissinger CA; Kempton CL; Lane H -
Mitral valve repair in a Jehovah's witness with haemophilia A with high-titre inhibitor
Haemophilia Volume: 21 Page(s): e523 - e525
11/01/2015 Authors: Tran DQ; Moss E; Murphy DA; Kempton CL -
Functional Impairment, Pain, and Pain Management in US Adult People with Hemophilia (PWH): Initial Lessons from the Pain, Functional
HAEMOPHILIA Volume: 21 Page(s): E543 - E543
11/01/2015 Authors: Baumann K; Akins S; Funk S; Hernandez G; Kempton C; Wang M; Buckner T; Cooper D -
Pain, Functional Impairment, and Quality of Life (P-FIQ): Reliability of Patient-Reported Outcome (PRO) Instruments Assessing Pain and Function in US Adult People With Hemophilia (PWH)
HAEMOPHILIA Volume: 21 Page(s): E551 - E552
11/01/2015 Authors: Wang M; Baumann K; Akins S; Funk S; Hernandez G; Kempton C; Buckner T; Cooper D -
Distress in patients with bleeding disorders: a single institutional cross-sectional study.
Haemophilia Volume: 21 Page(s): e456 - e464
11/01/2015 Authors: Barry V; Lynch ME; Tran DQ; Antun A; Cohen HG; DeBalsi A; Hicks D; Mattis S; Ribeiro MJA; Stein SF -
Inhibitor recurrence after immune tolerance induction: a multicenter retrospective cohort study.
J Thromb Haemost Volume: 13 Page(s): 1980 - 1988
11/01/2015 Authors: Antun A; Monahan PE; Manco-Johnson MJ; Callaghan MU; Kanin M; Knoll C; Carpenter SL; Davis JA; Guerrera MF; Kruse-Jarres R -
Mitral valve repair in a Jehovah's witness with haemophilia A with high-titre inhibitor.
Haemophilia Volume: 21 Page(s): e523 - e525
11/01/2015 Authors: Tran DQ; Moss E; Murphy DA; Kempton CL -
Continuation of all-trans retinoic acid despite the development of scrotal ulcerations in a black male.
J Oncol Pharm Pract Volume: 21 Page(s): 393 - 395
10/01/2015 Authors: Sutherland J; Kempton CL; Curry MA -
Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening.
Am J Hematol Volume: 90 Page(s): 871 - 876
10/01/2015 Authors: Miller CH; Rice AS; Boylan B; Payne AB; Kelly FM; Escobar MA; Gill J; Leissinger C; Soucie JM; Hemophilia Inhibitor Research Study Investigators -
Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network.
J Thromb Haemost Volume: 13 Page(s): 1585 - 1589
09/01/2015 Authors: Abshire T; Cox-Gill J; Kempton CL; Leebeek FWG; Carcao M; Kouides P; Donfield S; Berntorp E -
US Guidelines for immune tolerance induction in patients with haemophilia a and inhibitors.
Haemophilia Volume: 21 Page(s): 559 - 567
09/01/2015 Authors: Valentino LA; Kempton CL; Kruse-Jarres R; Mathew P; Meeks SL; Reiss UM; International Immune Tolerance Induction Study Investigators -
US Guidelines for immune tolerance induction in patients with haemophilia a and inhibitors
Haemophilia Volume: 21 Page(s): 559 - 567
09/01/2015 Authors: Valentino LA; Kempton CL; Kruse-Jarres R; Mathew P; Meeks SL; Reiss UM -
Bone health in persons with haemophilia.
Haemophilia Volume: 21 Page(s): 568 - 577
09/01/2015 Authors: Kempton CL; Antoniucci DM; Rodriguez-Merchan EC -
Changes in bleeding patterns in von Willebrand disease after institution of long-term replacement therapy: results from the von Willebrand Disease Prophylaxis Network.
Blood Coagul Fibrinolysis Volume: 26 Page(s): 383 - 388
06/01/2015 Authors: Holm E; Abshire TC; Bowen J; lvarez MT; Bolton-Maggs P; Carcao M; Federici AB; Gill JC; Halimeh S; Kempton C -
Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.
J Thromb Haemost Volume: 13 Page(s): 1036 - 1042
06/01/2015 Authors: Boylan B; Rice AS; De Staercke C; Eyster ME; Yaish HM; Knoll CM; Bean CJ; Miller CH; Hemophilia Inhibitor Research Study Investigators -
Reliability of patient-reported outcome (PRO) instruments in US adult people with hemophilia (pwh): the pain functional impairment and quality of life (P-FIQ) study
JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 13 Page(s): 363 - 363
06/01/2015 Authors: Wang M; Neff A; Shapiro A; Kulkarni R; Reding M; Kuriakose P; Kessler C; Witkop M; Kempton C; Cooper D -
Impact of pain and functional impairment in us adult people with hemophilia (PWH): results from retest population in the pain functional impairment and quality of life (P-FIQ) study
JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 13 Page(s): 860 - 860
06/01/2015 Authors: Kempton C; Recht M; Neff A; Wang M; Buckner T; Nugent D; Quon D; Witkop M; Boggio L; Cooper D -
Race and the immune response to factor VIII replacement therapy
JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 13 Page(s): 352 - 352
06/01/2015 Authors: Mann KG; Butenas S; Pierce G; Peters R; Tan S; Lusher J; Lillicrap D; Kempton C; Mahlangu J; Ameri A -
Factor VIII inhibitors in patients with non-severe hemophilia
JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 13 Page(s): 78 - 79
06/01/2015 Authors: Kempton CL -
Prevalence, description, and management of pain in adult people with hemophilia (PWH): initial lessons from the pain functional impairment and quality of life (P-FIQ) study
JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 13 Page(s): 860 - 860
06/01/2015 Authors: Buckner T; Witkop M; Wang M; Recht M; Batt K; Cooper D; Kempton C -
Spinart trial 3-year results with bayer's sucrose-formulated recombinant factor VIII: relationship between bleeding frequency and joint health in adults with severe hemophilia A using prophylaxis
JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 13 Page(s): 132 - 132
06/01/2015 Authors: Reding MT; Kempton CL; Funk S; Engelen S; Walker D; Hong W -
Safety of Turoctocog Alfa in Previously Treated Patients with Hemophilia A: A US Perspective from the Guardian (TM) Clinical Trials
HAEMOPHILIA Volume: 21 Page(s): E267 - E267
05/01/2015 Authors: Lentz S; Kempton C; Zeuthen N; Cooper D -
PAIN FUNCTIONAL IMPAIRMENT AND QUALITY OF LIFE (P-FIQ): AN ASSESSMENT OF RELIABILITY OF FIVE PATIENT REPORTED OUTCOME (PRO) INSTRUMENTS IN ADULT PEOPLE WITH HEMOPHILIA (PWH)
VALUE IN HEALTH Volume: 18 Page(s): A301 - A302
05/01/2015 Authors: Kempton CL; Wang M; Recht M; Neff A; Shapiro AD; Buckner T; Kulkarni R; Nugent D; Batt K; Wisniewski T -
Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay.
J Thromb Haemost Volume: 13 Page(s): 47 - 53
01/01/2015 Authors: Boylan B; Rice AS; Dunn AL; Tarantino MD; Brettler DB; Barrett JC; Miller CH; Hemophilia Inhibitor Research Study Investigators; Hemophilia Inhibitor Research Study Investigators -
The Impact of Health Literacy on Adherence to Factor Replacement in the Hemophilia Population
BLOOD Volume: 124
12/06/2014 Authors: Tran DQ; Barry V; Antun AG; Ribeiro MJA; Stein SF; Kempton CL -
A Cross-Sectional Analysis of Cardiovascular Disease in the Hemophilia Population
BLOOD Volume: 124
12/06/2014 Authors: Sood SL; Cheng D; Shapiro AD; Kessler CM; Key NS; Quon DV; Eyster E; Manco-Johnson MJ; Kempton CL; Fogarty PF -
Toward optimal therapy for inhibitors in hemophilia.
Hematology Am Soc Hematol Educ Program Volume: 2014 Page(s): 364 - 371
12/05/2014 Authors: Kempton CL; Meeks SL -
Toward optimal therapy for inhibitors in hemophilia.
Blood Volume: 124 Page(s): 3365 - 3372
11/27/2014 Authors: Kempton CL; Meeks SL -
Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa.
J Thromb Haemost Volume: 12 Page(s): 1244 - 1253
08/01/2014 Authors: Lentz SR; Ehrenforth S; Karim FA; Matsushita T; Weldingh KN; Windyga J; Mahlangu JN; adept2 investigators -
Use of factor VIII after inhibitor clearance in patients with moderate haemophilia A: a case series.
Haemophilia Volume: 20 Page(s): e344 - e346
07/01/2014 Authors: Tran DQ; Harvey RD; Meeks SL; Chapman R; Kempton CL -
Modifiers of self-efficacy in patients with hemophilia
HAEMOPHILIA Volume: 20 Page(s): 162 - 162
05/01/2014 Authors: Tran D; Antun A; Ribeiro M; Stein S; Kempton C -
3-year results from SPINART: prophylaxis vs on-demand treatment with sucrose-formulated recombinant factor VIII
HAEMOPHILIA Volume: 20 Page(s): 96 - 96
05/01/2014 Authors: Manco-Johnson MJ; Kempton CL; Reding MT; Goranov S; Gercheva L; Rusen L; Uscatescu V; Pierdominici M; Walker D; Hong W -
The role of disease severity in influencing body mass index in people with haemophilia: a single-institutional cross-sectional study.
Haemophilia Volume: 20 Page(s): 190 - 195
03/01/2014 Authors: McNamara M; Antun A; Kempton CL -
A study of prospective surveillance for inhibitors among persons with haemophilia in the United States.
Haemophilia Volume: 20 Page(s): 230 - 237
03/01/2014 Authors: Soucie JM; Miller CH; Kelly FM; Payne AB; Creary M; Bockenstedt PL; Kempton CL; Manco-Johnson MJ; Neff AT; Haemophilia Inhibitor Research Study Investigators -
Prevalent inhibitors in haemophilia B subjects enrolled in the Universal Data Collection database.
Haemophilia Volume: 20 Page(s): 25 - 31
01/01/2014 Authors: Puetz J; Soucie JM; Kempton CL; Monahan PE; Hemophilia Treatment Center Network (HTCN) Investigators -
Bone density in haemophilia: a single institutional cross-sectional study.
Haemophilia Volume: 20 Page(s): 121 - 128
01/01/2014 Authors: Kempton CL; Antun A; Antoniucci DM; Carpenter W; Ribeiro M; Stein S; Slovensky L; Elon L -
Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART) (vol 11, pg 1119, 2013)
JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 12 Page(s): 119 - 122
01/01/2014 Authors: Manco-Johnson MJ; Kempton CL; Reding MT; Lissitchkov T; Goranov S; Gercheva L; Rusen L; Ghinea M; Uscatescu V; Rescia V -
Use of factor VIII after inhibitor clearance in patients with moderate haemophilia A: A case series
Haemophilia Volume: 20
01/01/2014 Authors: Tran DQ; Harvey RD; Meeks SL; Chapman R; Kempton CL -
Detection of non inhibitory binding antibodies to von Willebrand factor affecting the clearance of VWF: AG in von willebrand disease
JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 11 Page(s): 97 - 98
12/01/2013 Authors: Suiter T; Mannucci PM; Kempton CL; Laffan M; Romond EH; Shapiro AD; Birschmann I; Ragni M; Gill JC; Yee TT -
Natural History Of Inhibitor Recurrence Following Successful Immune Tolerance Induction
Volume: 122
11/15/2013 Authors: Antun AG; Monahan P; Manco-Johnson MJ; Callaghan M; Young G; Knoll C; Carpenter S; Davis JA; Guerrera MF; Kruse-Jarres R -
Postoperative Deep Vein Thrombosis (DVT) In Patients With Hemophilia Undergoing Major Orthopedic Surgery
Volume: 122
11/15/2013 Authors: Buckner TW; Andrew L; Ragni MV; Eyster ME; Kempton CL; Key NS -
Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A.
Nat Med Volume: 19 Page(s): 1318 - 1324
10/01/2013 Authors: Pandey GS; Yanover C; Miller-Jenkins LM; Garfield S; Cole SA; Curran JE; Moses EK; Rydz N; Simhadri V; Kimchi-Sarfaty C -
Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial.
Blood Volume: 122 Page(s): 648 - 657
08/01/2013 Authors: Mannucci PM; Kempton C; Millar C; Romond E; Shapiro A; Birschmann I; Ragni MV; Gill JC; Yee TT; Klamroth R -
Physical activity and functional abilities in adult males with haemophilia: a cross-sectional survey from a single US haemophilia treatment centre.
Haemophilia Volume: 19 Page(s): 551 - 557
07/01/2013 Authors: Baumgardner J; Elon L; Antun A; Stein S; Ribeiro M; Slovensky L; Kempton CL -
Thrombotic Thrombocytopenic Purpura
Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects: Second Edition Page(s): 675 - 680
06/11/2013 Authors: Kempton CL -
Acquired Coagulation Factor Inhibitors
Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects: Second Edition Page(s): 781 - 786
06/11/2013 Authors: Kempton CL -
Bleeding Disorders in Pregnancy
Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects: Second Edition Page(s): 729 - 735
06/11/2013 Authors: Kempton CL -
Laboratory Evaluation of Thrombotic Thrombocytopenic Purpura
Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects: Second Edition Page(s): 867 - 870
06/11/2013 Authors: Kempton CL -
Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factorVIII in adults with severe hemophiliaA (SPINART).
J Thromb Haemost Volume: 11 Page(s): 1119 - 1127
06/01/2013 Authors: Manco-Johnson MJ; Kempton CL; Reding MT; Lissitchkov T; Goranov S; Gercheva L; Rusen L; Ghinea M; Uscatescu V; Rescia V -
Late immune tolerance induction in haemophilia A patients.
Haemophilia Volume: 19 Page(s): 445 - 448
05/01/2013 Authors: Meeks SL; Chapman RL; Kempton C; Dunn AL -
A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A.
Hum Mol Genet Volume: 22 Page(s): 1903 - 1910
05/01/2013 Authors: Lane J; McLaren PJ; Dorrell L; Shianna KV; Stemke A; Pelak K; Moore S; Oldenburg J; Alvarez-Roman MT; Angelillo-Scherrer A -
Bleeding frequency subanalyses in a randomized controlled trial of prophylaxis vs on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A
HAEMOPHILIA Volume: 19 Page(s): 28 - 29
02/01/2013 Authors: Zarkova AG; Kempton CL; Reding MT; Lissitchkov T; Goranov S; Gercheva L; Rusen L; Ghinea M; Uscatescu V; Rescia V -
Phenotypes of allo- and autoimmune antibody responses to FVIII characterized by surface plasmon resonance.
PLoS One Volume: 8 Page(s): e61120
01/01/2013 Authors: Lewis KB; Hughes RJ; Epstein MS; Josephson NC; Kempton CL; Kessler CM; Key NS; Howard TE; Kruse-Jarres R; Lusher JM -
Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysis.
Haemophilia Volume: 18 Page(s): 881 - 887
11/01/2012 Authors: Martinowitz U; Shapiro A; Quon DV; Escobar M; Kempton C; Collins PW; Chowdary P; Makris M; Mannucci PM; Morfini M -
Eradication of factor VIII inhibitors in patients with mild and moderate hemophilia A.
Am J Hematol Volume: 87 Page(s): 933 - 936
09/01/2012 Authors: Kempton CL; Allen G; Hord J; Kruse-Jarres R; Pruthi RK; Walsh C; Young G; Soucie JM -
Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia A.
Haemophilia Volume: 18 Page(s): 798 - 804
09/01/2012 Authors: Kempton CL; Abshire TC; Deveras RA; Hoots WK; Gill JC; Kessler CM; Key NS; Konkle BA; Kuriakose P; Macfarlane DE -
Randomized, controlled, parallel-group trial of secondary prophylaxis vs on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A
HAEMOPHILIA Volume: 18 Page(s): 830 - 831
09/01/2012 Authors: Kempton C; Valluri S; Reding M; Lissitchkov T; Goranov S; Gercheva L; Rusen L; Ghinea M; Uscatescu V; Rescia V -
Detection of non-inhibitory binding antibodies to von Willebrand factor affecting the clearance of VWF:Ag in von Willebrand disease
HAEMOPHILIA Volume: 18 Page(s): 200 - 200
07/01/2012 Authors: Suiter TM; Mannucci PM; Kempton CL; Laffan M; Romond EH; Shapiro AD; Birschmann I; Ragni MV; Gill JC; Klamroth R -
Regional differences in baseline patient-reported outcomes in a randomized, controlled, prospective trial of secondary prophylaxis VS on-demand treatment in patients with severe hemophilia A
HAEMOPHILIA Volume: 18 Page(s): 25 - 25
07/01/2012 Authors: Kempton C; Valluri S; Reding M; Lissitchkov T; Goranov S; Gercheva L; Rusen L; Ghinea M; Uscatescu V; Rescia V -
Detection of non inhibitory binding antibodies to von Willebrand factor affecting the clearance of VWF:Ag in von Willebrand disease
HAEMOPHILIA Volume: 18 Page(s): 42 - 43
03/01/2012 Authors: Suiter TM; Mannucci PM; Kempton C; Laffan M; Romond EH; Shapiro A; Birschmann I; Ragni MV; Gill JC; Yee TT -
Use of IB1001, a new investigational recombinant factor IX, in patients with hemophilia B undergoing major surgical procedures
HAEMOPHILIA Volume: 18 Page(s): 40 - 41
03/01/2012 Authors: Lee ML; Apte SJ; Morfini M; Ramanan V; Escobar M; Kempton C; Lubetsky A; Valentino L; Makris M; Negrier C -
Pharmacokinetic Behavior of IB1001, An Investigational Recombinant Factor IX, in Patients with Hemophilia B: Repeat Pharmacokinetic Study and Subgroup Analysis
Volume: 118 Page(s): 984 - 985
11/18/2011 Authors: Martinowitz U; Shapiro AD; Quon DV; Escobar MA; Kempton CL; Collins P; Chowdary P; Makris M; Mannucci PM; Morfini M -
Detection of Non Inhibitory Binding Antibodies to Von Willebrand Factor Affecting the Clearance of VWF:Ag in Von Willebrand Disease
Volume: 118 Page(s): 987 - 988
11/18/2011 Authors: Suiter TM; Mannucci PM; Kempton CL; Laffan M; Romond EH; Shapiro AD; Birschmann I; Ragni MV; Gill JC; Yee TT -
Recombinant human von Willebrand factor-plasma free manufactured: first-in-human study evaluating pharmacokinetics, demonstrating safety and tolerability in severe VWD
JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 9 Page(s): 288 - 288
07/01/2011 Authors: Mannucci PM; Kempton CL; Laffan MA; Romond EH; Shapiro A; Birschmann I; Ragni M; Gill JC; Yee TT; Klamroth R -
Inhibitors in mild and moderate hemophilia A: a heterogeneous problem
JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 9 Page(s): 932 - 932
07/01/2011 Authors: Kempton CL; Allen G; Gauger C; Hord J; Kruse-Jarres R; Pruthi R; Walsh C; Young G; Soucie JM -
Screening for von Willebrand disease in children: a case-control study.
J Thromb Haemost Volume: 9 Page(s): 1086 - 1089
05/01/2011 Authors: Bujnicki HC; Sidonio RF; Kempton C; Kouides PA; Kulkarni R; Nugent DJ; Yee DL; Moore CG; Ragni MV -
Factor VIII A3 domain substitution N1922S results in hemophilia A due to domain-specific misfolding and hyposecretion of functional protein.
Blood Volume: 117 Page(s): 3190 - 3198
03/17/2011 Authors: Summers RJ; Meeks SL; Healey JF; Brown HC; Parker ET; Kempton CL; Doering CB; Lollar P -
Recombinant human von Willebrand factor - plasma free manufactured (RHVWF-PFM): first-in-human study evaluating pharmacokinetics, demonstrating safety and tolerability in severe von Willebrand's disease
HAEMOPHILIA Volume: 17 Page(s): 358 - 359
03/01/2011 Authors: Suiter TM; Laffan M; Mannucci P; Kempton C; Romond E; Shapiro A; Klamroth R; Birschmann I; Gill JC; Ragni M -
Pharmacokinetics of IB1001, a new recombinant factor IX
HAEMOPHILIA Volume: 17 Page(s): 355 - 355
03/01/2011 Authors: Martinowitz U; Shapiro A; Quon D; Escobar M; Kempton C; Collins P; Chowdary P; Makris M; Mannucci P; Morfini M -
INCREASED PERMEABILITY OF THE SMALL INTESTINE WALL IN TYPE 2 DIABETIC PATIENTS WITH NEPHROPATHY AND LABORATORY EVIDENCE OF SYSTEMIC INFLAMMATION
Volume: 59 Page(s): 532 - 532
02/01/2011 Authors: Odunsi A; Flood K; Wells S; Kempton C; Al-Shahrouri H; Forsyth C; Shaikh M; Keshavarzian A; Fanti P -
Evaluation of factor VIII pharmacokinetics and anti-factor VIII antibodies in four boys with haemophilia A and a poor clinical response to factor VIII.
Haemophilia Volume: 17 Page(s): 155 - 156
01/01/2011 Authors: Kempton CL; Meeks SL; Donald Harvey R; Abshire TC -
Recombinant Human Von Willebrand Factor (rhVWF): First-In-Human Study Evaluating Pharmacokinetics, Demonstrating Safety and Tolerability In Type 3 Von Willebrand Disease
Volume: 116 Page(s): 110 - 110
11/19/2010 Authors: Suiter T; Laffan M; Mannucci PM; Kempton CL; Romond EH; Shapiro AD; Birschmann I; Gill JC; Ragni MV; Turecek P -
Predictors of Von Willebrand Disease In Children: A Case-Control Study
Volume: 116 Page(s): 314 - 314
11/19/2010 Authors: Bujnicki HL; Sidonio RF; Moore CG; Kempton CL; Kouides PA; Kulkarni R; Nugent DJ; Yee DL; Ragni MV -
N1922S Mutation In the Factor VIII A3 Domain Produces a Rate-Limiting, Domain-Specific Folding Defect Leading to Hyposecretion of a Functional Protein.
Volume: 116 Page(s): 910 - 910
11/19/2010 Authors: Summers RJ; Meeks SL; Healey JF; Brown HC; Parker ET; Doering C; Kempton CL; Lollar JPS -
In non-severe hemophilia A the risk of inhibitor after intensive factor treatment is greater in older patients: a case-control study.
J Thromb Haemost Volume: 8 Page(s): 2224 - 2231
10/01/2010 Authors: Kempton CL; Soucie JM; Miller CH; Hooper C; Escobar MA; Cohen AJ; Key NS; Thompson AR; Abshire TC -
Inhibitors in previously treated patients: a review of the literature.
Haemophilia Volume: 16 Page(s): 61 - 65
05/01/2010 Authors: Kempton CL -
Risk Factors for Inhibitor Development in Mild and Moderate Hemophilia A: A Case-Control Study
Volume: 114 Page(s): 1234 - 1234
11/20/2009 Authors: Kempton CL; Soucie JM; Miller CH; Hooper C; Escobar MA; Reding MT; Cohen AJ; Key NS; Thompson AR; Manco-Johnsons MJ -
The Role of Immune-Response Gene Variants in Inhibitor Development in Black Patients with Hemophilia
Volume: 114 Page(s): 533 - 533
11/20/2009 Authors: Howard TE; Cole SA; Kasper CK; Ameri A; Natarajan K; Watts RG; Manard VA; Nakaya SM; Kempton CL; Kennedy M -
Immune tolerance in patients with hemophilia A and longstanding inhibitors
Volume: 7 Page(s): 518 - 519
07/01/2009 Authors: Dunn AL; Meeks SL; Chapman RL; Kempton CL -
ADAMTS13 testing
Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects Page(s): 635 - 638
06/08/2009 Authors: Kempton CL -
Factor VII concentrates
Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects Page(s): 739 - 741
06/08/2009 Authors: Kempton CL -
Bleeding disorders in pregnancy
Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects Page(s): 555 - 559
06/08/2009 Authors: Kempton CL -
Acquired coagulation factor inhibitors
Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects Page(s): 595 - 600
06/08/2009 Authors: Kempton CL -
Prothrombin complex concentrates
Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects Page(s): 721 - 723
06/08/2009 Authors: Kempton CL -
Heparin-induced thrombocytopenia
Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects Page(s): 491 - 497
06/08/2009 Authors: Kempton CL -
Thrombotic thrombocytopenic purpura
Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects Page(s): 509 - 513
06/08/2009 Authors: Kempton CL -
Recommendations for the treatment of knee osteoarthritis, using various therapy techniques, based on categorizations of a literature review.
J Geriatr Phys Ther Volume: 32 Page(s): 33 - 38
01/01/2009 Authors: Thomas A; Eichenberger G; Kempton C; Pape D; York S; Decker AM; Kohia M -
How we treat a hemophilia A patient with a factor VIII inhibitor.
Blood Volume: 113 Page(s): 11 - 17
01/01/2009 Authors: Kempton CL; White GC -
Copper Deficiency Remains An Underappreciated Cause of Ineffective Hematopoiesis
Volume: 112 Page(s): 1062 - 1062
11/16/2008 Authors: Langston A; Neely J; Heffner L; Griffith D; Arellano M; Esper G; McLemore ML; Ziegler T; Kempton C; Sinha R -
A phase II open-label study evaluating the hemostatic activity, pharmacokinetics and safety of recombinant porcine factor VIII (OBI-1) in hemophilia A patients with inhibitors directed against human FVIII
HAEMOPHILIA Volume: 14 Page(s): 15 - 16
07/01/2008 Authors: Mahlangu J; Andreeva T; Macfarlane D; Reding M; Walsh C; Ewing N; Kessler M; Kempton C; Mathew P; Plyushch O -
Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma.
Anesth Analg Volume: 106 Page(s): 719 - 724
03/01/2008 Authors: Szlam F; Taketomi T; Sheppard CA; Kempton CL; Levy JH; Tanaka KA -
A phase II open-label study evaluating hemostatic activity, pharmacokinetics and safety of recombinant porcine factor VIII (OBI-1) in hemophilia A patients with alloantibody inhibitors directed against human FVIII
Volume: 110 Page(s): 241A - 241A
11/16/2007 Authors: Mahlangu J; Andreeva TA; Macfarlane D; Reding MT; Walsh C; Ritchie B; Ewing N; Kessler CM; Kempton C; Libby E -
Incidence of inhibitors in a cohort of 838 males with hemophilia A previously treated with factor VIII concentrates (vol 4, pg 2576. 2006)
JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 5 Page(s): 657 - 657
03/01/2007 Authors: Kempton CL; Soucie JM; Abshire TC -
Erratum: (Journal of Thrombosis Haemostasis)
Journal of Thrombosis and Haemostasis Volume: 5 Page(s): 657
03/01/2007 Authors: Kempton CL; Soucie JM; Abshire TC -
Rare Platelet and Coagulation Disorders
Page(s): 129 - 160
01/01/2007 Authors: Berntorp E; Ingerslev J; Roberts HR; Kempton C; Macik G; Key NS; Arranz P; Rickard K; Briet E; Koopman M -
Incidence of inhibitors in a cohort of 838 males with hemophilia A previously treated with factor VIII concentrates.
J Thromb Haemost Volume: 4 Page(s): 2576 - 2581
12/01/2006 Authors: Kempton CL; Soucie JM; Abshire TC -
Application of current knowledge to the management of bleeding events during immune tolerance induction.
Haemophilia Volume: 12 Page(s): 591 - 597
11/01/2006 Authors: Di Paola J; Aledort L; Britton H; Carcao M; Grabowski E; Hutter J; Journeycake J; Kempton C; Leissinger C -
Novel therapeutic agents in the management of hemorrhage and thrombosis.
Cardiovasc Hematol Agents Med Chem Volume: 4 Page(s): 319 - 334
10/01/2006 Authors: Kempton CL; Harvey RD; Roberts HR -
Cellular immune responses in hemophilia: why do inhibitors develop in some, but not all hemophiliacs?
Volume: 3 Page(s): 1676 - 1681
08/01/2005 Authors: White GC; Kempton CL; Grimsley A; Nielsen B; Roberts HR -
Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations.
Arterioscler Thromb Vasc Biol Volume: 25 Page(s): 861 - 866
04/01/2005 Authors: Kempton CL; Hoffman M; Roberts HR; Monroe DM -
COAT platelet formation is P2Y 12-dependent
Volume: 104 Page(s): 437A - 438A
11/16/2004 Authors: Kempton CL; Hoffman M; Lenkowski A; Roberts HR; Monroe DM -
Hemophilia care in the 21st century.
Clin Adv Hematol Oncol Volume: 2 Page(s): 733 - 740
11/01/2004 Authors: Kempton CL; Escobar MA; Roberts HR -
Platelets stimulated with convulxin plus thrombin develop platelet subpopulations with increased binding of factor VIII, factor IX, and factor X.
Volume: 102 Page(s): 293A - 293A
11/16/2003 Authors: Kempton CL; Hoffman M; Meng ZH; Roberts HR; Monroe DM -
Successful treatment of an autoantibody in congenital hemophilia with Rituximab.
Volume: 100 Page(s): 109B - 109B
11/16/2002 Authors: Escobar M; Kempton C; Ma A -
Ulcerative colitis presenting as purpura fulminans.
Inflamm Bowel Dis Volume: 7 Page(s): 319 - 322
11/01/2001 Authors: Kempton CL; Bagby G; Collins JF -
Malignant lymphoma of the bladder: evidence from 36 cases that low-grade lymphoma of the MALT-type is the most common primary bladder lymphoma.
Am J Surg Pathol Volume: 21 Page(s): 1324 - 1333
11/01/1997 Authors: Kempton CL; Kurtin PJ; Inwards DJ; Wollan P; Bostwick DG -
Preferential attachment of prostate carcinoma cells to fibronectin: Role of bone matrix in metastatic disease.
JOURNAL OF INVESTIGATIVE MEDICINE Volume: 44 Page(s): A375 - A375
09/01/1996 Authors: Kempton C; Ritchie CK; Fitzpatrick LA -
Preferential attachment of prostate carcinoma cells to fibronectin: Role of bone matrix in metastatic disease.
JOURNAL OF BONE AND MINERAL RESEARCH Volume: 11 Page(s): T723 - T723
08/01/1996 Authors: Ritchie CK; Kempton CL; Fitzpatrick LA